Molecular recognition of human liver cancer cells using DNA aptamers generated via cell-SELEX

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Xu, Jiehua ^a,b   Teng, I Ting ^b   Zhang, Liqin ^b   Delgado, Stefanie ^b   Champanhac, Carole ^b   Cansiz, Sena ^b   Wu, Cuichen ^b   Shan, Hong ^a   Tan, Weihong ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; MEMBRANE PROTEIN; PROTEINASE; SINGLE STRANDED DNA;

ANALYTIC METHOD; ARTICLE; BINDING AFFINITY; CANCER DIAGNOSIS; CELL ASSAY; CELL SELECTION; CELL SURFACE; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISSOCIATION CONSTANT; DNA SEQUENCE; EARLY DIAGNOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CANCER CELL LINE; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER CELL LINE; MOLECULAR PROBE; MOLECULAR RECOGNITION; OVARIAN CANCER CELL LINE; PERFORMANCE MEASUREMENT SYSTEM; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTEIN INTERACTION; TARGET CELL; CHEMISTRY; EPITHELIUM CELL; GENE LIBRARY; HEP-G2 CELL LINE; LIVER TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE; TUMOR CELL LINE;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; EPITHELIAL CELLS; FLOW CYTOMETRY; GENE LIBRARY; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; SELEX APTAMER TECHNIQUE;

EID: 84929094393     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125863     Document Type: Article

References (48)

1. Verslype C, Rosmorduc O, Rougier P, Group EGW. Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012; 23 Suppl 7:vii41-48. PMID: 22997453
2. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990; 346:818-822. PMID: 1697402
3. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990; 249:505-510. PMID: 2200121
4. Shangguan D, Li Y, Tang Z, Cao ZC, Chen HW, Mallikaratchy P, et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A. 2006; 103:11838-11843. PMID: 16873550
5. Shangguan D, Cao Z, Meng L, Mallikaratchy P, Sefah K, Wang H, et al. Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J Proteome Res. 2008; 7:2133-2139. doi: 10.1021/pr700894d PMID: 18363322
6. Chang YM, Donovan MJ, Tan W. Using aptamers for cancer biomarker discovery. J Nucleic Acids. 2013; 2013:817350. doi: 10.1155/2013/817350 PMID: 23401749
7. Morris KN, Jensen KB, Julin CM, Weil M, Gold L. High affinity ligands from in vitro selection: complex targets. Proc Natl Acad Sci U S A. 1998; 95:2902-2907. PMID: 9501188
8. Sefah K, Tang ZW, Shangguan DH, Chen H, Lopez-Colon D, Li Y, et al. Molecular recognition of acute myeloid leukemia using aptamers. Leukemia. 2009; 23:235-244. doi: 10.1038/leu.2008.335 PMID: 19151784
9. Sefah K, Meng L, Lopez-Colon D, Jimenez E, Liu C, Tan W. DNA aptamers as molecular probes for colorectal cancer study. PLoS ONE. 2010; 5:e14269. doi: 10.1371/journal.pone.0014269 PMID: 21170319
10. Zhang K, Sefah K, Tang L, Zhao Z, Zhu G, Ye M, et al. A novel aptamer developed for breast cancer cell internalization. ChemMedChem. 2012; 7:79-84. doi: 10.1002/cmdc.201100457 PMID: 22170627
11. Van Simaeys D, López-Colón D, Sefah K, Sutphen R, Jimenez E, Tan W. Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX. PLoS ONE. 2010; 5:e13770. doi: 10.1371/journal.pone.0013770 PMID: 21072169
12. Chen HW, Medley CD, Sefah K, Shangguan D, Tang Z, Meng L, et al. Molecular recognition of small-cell lung cancer cells using aptamers. ChemMedChem. 2008; 3:991-1001. doi: 10.1002/cmdc.200800030 PMID: 18338423
13. Zhao Z, Xu L, Shi X, Tan W, Fang X, Shangguan D. Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells. Analyst. 2009; 134:1808-1814. doi: 10.1039/b904476k PMID: 19684903
14. Jimenez E, Sefah K, Lopez-Colon D, Van Simaeys D, Chen HW, Tockman MS, et al. Generation of lung adenocarcinoma DNA aptamers for cancer studies. PLoS ONE. 2012; 7:e46222. doi: 10.1371/journal.pone.0046222 PMID: 23082117
15. Dua P, Kang HS, Hong SM, Tsao MS, Kim S, Lee DK. Alkalinephosphatase ALPPL-2 is a novel pancreatic carcinoma-associated protein. Cancer Res. 2013; 73:1934-1945. doi: 10.1158/0008-5472.CAN-12-3682 PMID: 23467613
16. Shigdar S, Qiao L, Zhou SF, Xiang D, Wang T, Li Y, et al. RNA aptamers targeting cancer stem cell marker CD133. Cancer Lett. 2013; 330:84-95. doi: 10.1016/j.canlet.2012.11.032 PMID: 23196060
17. Li N, Nguyen HH, Byrom M, Ellington AD. Inhibition of cell proliferation by an anti-EGFR aptamer. PLoS ONE. 2011; 6:e20299. doi: 10.1371/journal.pone.0020299 PMID: 21687663
18. Dastjerdi K, Tabar GH, Dehghani H, Haghparast A. Generation of an enriched pool of DNA aptamers for an HER2-overexpressing cell line selected by Cell SELEX. Biotechnol Appl Biochem. 2011; 58(4): 226-230. doi: 10.1002/bab.36 PMID: 21838796
19. Liu Z, Duan JH, Song YM, Ma J, Wang FD, Lu X, et al. Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro. J Transl Med. 2012; 10:148.
20. Mallikaratchy P, Tang Z, Kwame S, Meng L, Shangguan D, Tan W. Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells. Mol Cell Proteomics. 2007; 6:2230-2238. PMID: 17875608
21. Xing H, Wong NY, Xiang Y, Lu Y. DNA aptamer functionalized nanomaterials for intracellular analysis, cancer cell imaging and drug delivery. Curr Opin Chem Biol. 2012; 16:429-435. doi: 10.1016/j.cbpa.2012.03.016 PMID: 22541663
22. Mairal T, Nadal P, Svobodova M, O'Sullivan CK. FRET-based dimeric aptamer probe for selective and sensitive Lup an 1 allergen detection. Biosens Bioelectron. 2014; 54:207-210. doi: 10.1016/j.bios.2013.10.070 PMID: 24280051
23. Hu K, Liu J, Chen J, Huang Y, Zhao S, Tian J, et al. An amplified graphene oxide-based fluorescence aptasensor based on target-triggered aptamer hairpin switch and strand-displacement polymerization recycling for bioassays. Biosens Bioelectron. 2013; 42:598-602. doi: 10.1016/j.bios.2012.11.025 PMID: 23261695
24. Shi H, Cui W, He X, Guo Q, Wang K, Ye X, et al. Whole cell-SELEX aptamers for highly specific fluorescence molecular imaging of carcinomas in vivo. PLoS ONE. 2013; 8:e70476. doi: 10.1371/journal.pone.0070476 PMID: 23950940
25. Xiao SJ, Hu PP, Chen LQ, Zhen SJ, Peng L, Li YF, et al. A visual dual-aptamer logic gate for sensitive discrimination of prion diseases-associated isoform with reusable magnetic microparticles and fluorescence quantum dots. PLoS ONE. 2013; 8:e53935. doi: 10.1371/journal.pone.0053935 PMID: 23393552
26. Cho S, Lee SH, Chung WJ, Kim YK, Lee YS, Kim BG. Microbead-based affinity chromatography chip using RNA aptamer modified with photocleavable linker. Electrophoresis. 2004; 25:3730-3739. PMID: 15565696
27. Balamurugan S, Obubuafo A, McCarley RL, Soper SA, Spivak DA. Effect of linker structure on surface density of aptamer monolayers and their corresponding protein binding efficiency. Anal Chem. 2008;80:9630-9634. doi: 10.1021/ac8009559 PMID: 18989937
28. Huang YF, Shangguan D, Liu H, Phillips JA, Zhang X, Chen Y, et al. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Chembiochem. 2009; 10:862-868. doi: 10.1002/cbic.200800805 PMID: 19253922
29. Donovan MJ, Meng L, Chen T, Zhang Y, Sefah K, Tan W. Aptamer-drug conjugation for targeted tumor cell therapy. Methods Mol Biol. 2011; 764:141-152. doi: 10.1007/978-1-61779-188-8-9 PMID: 21748638
30. Li X, Zhao Q, Qiu L. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy. J Control Release. 2013; 171:152-162. doi: 10.1016/j.jconrel.2013.06.006 PMID: 23777885
31. Shigdar S, Macdonald J, O'Connor M, Wang T, Xiang D, Al Shamaileh H, et al. Aptamers as theranostic agents: modifications, serum stability and functionalisation. Sensors (Basel). 2013; 13:13624-13637. doi: 10.3390/s131013624 PMID: 24152925
32. Wang RE, Wu H, Niu Y, Cai J. Improving the stability of aptamers by chemical modification. Curr Med Chem. 2011; 18:4126-4138. PMID: 21838692
33. Medley CD, Bamrungsap S, Tan W, Smith JE. Aptamer-conjugated nanoparticles for cancer cell detection. Anal Chem. 2011; 83:727-734. doi: 10.1021/ac102263v PMID: 21218774
34. Fang X, Tan W. Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc Chem Res. 2010; 43:48-57. doi: 10.1021/ar900101s PMID: 19751057
35. Liu H, Xiang Y, Lu Y, Crooks RM. Aptamer-based origami paper analytical device for electrochemical detection of adenosine. Angew Chem Int Ed Engl. 2012; 51:6925-6928. doi: 10.1002/anie.201202929 PMID: 22639438
36. Schoukroun-Barnes LR, Wagan S, White RJ. Enhancing the analytical performance of electrochemical RNA aptamer-based sensors for sensitive detection of aminoglycoside antibiotics. Anal Chem. 2014; 86:1131-1137. doi: 10.1021/ac4029054 PMID: 24377296
37. Banerjee J, Nilsen-Hamilton M. Aptamers: multifunctional molecules for biomedical research. J Mol Med (Berl). 2013; 91:1333-1342. doi: 10.1007/s00109-013-1085-2 PMID: 24045702
38. Kong HY, Byun J. Nucleic Acid aptamers: new methods for selection, stabilization, and application in biomedical science. Biomol Ther (Seoul). 2013; 21:423-434. doi: 10.4062/biomolther.2013.085 PMID: 24404332
39. Zhou W, Huang PJ, Ding J, Liu J. Aptamer-based biosensors for biomedical diagnostics. Analyst. 2014; 139:2627-2640. doi: 10.1039/c4an00132j PMID: 24733714
40. Ng EW, Shima DT, Calias P, Cunningham ET, Guyer DR, Adamis AP. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov. 2006; 5:123-132. PMID: 16518379
41. Keefe AD, Pai S, Ellington A. Aptamers as therapeutics. Nat Rev Drug Discov. 2010; 9:537-550. doi: 10.1038/nrd3141 PMID: 20592747
42. Sun H, Zhu X, Lu PY, Rosato RR, Tan W, Zu Y. Oligonucleotide aptamers: new tools for targeted cancer therapy. Mol Ther Nucleic Acids. 2014; 3:e182. doi: 10.1038/mtna.2014.32 PMID: 25093706
43. Jelic S, Sotiropoulos GC, Group EGW. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010; 21 Suppl 5:v59-64. doi: 10.1093/annonc/mdq166 PMID: 20555104
44. Sefah K, Shangguan D, Xiong X, O'Donoghue MB, Tan W. Development of DNA aptamers using Cell-SELEX. Nat Protoc. 2010; 5:1169-1185. doi: 10.1038/nprot.2010.66 PMID: 20539292
45. Li H, He Y, Ding G, Wang C, Xie L, Li Y. dbDEPC: a database of differentially expressed proteins in human cancers. Nucleic Acids Res. 2010; 38:D658-664. doi: 10.1093/nar/gkp933 PMID: 19900968
46. Zhao J, Lee SH, Huss M, Holme P. The network organization of cancer-associated protein complexes in human tissues. Sci Rep. 2013; 3:1583. doi: 10.1038/srep01583 PMID: 23567845
47. Lee Y-TM, Geer DA. Primary liver cancer: Pattern of metastasis. J Surg Oncol. 1987; 36:26-31. PMID: 3041113
48. Subik K, Lee JF, Baxter L, Strzepek T, Costello D, Crowley P, et al. The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines. Breast Cancer (Auckl). 2010; 4:35-41. PMID: 20697531